SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-146185
Filing Date
2020-05-19
Accepted
2020-05-19 16:30:50
Documents
17
Period of Report
2020-05-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d812767d8k.htm   iXBRL 8-K 36882
2 EX-1.1 d812767dex11.htm EX-1.1 153088
3 EX-1.2 d812767dex12.htm EX-1.2 50226
4 EX-99.1 d812767dex991.htm EX-99.1 10518
9 GRAPHIC g812767g0519113236537.jpg GRAPHIC 2492
  Complete submission text file 0001193125-20-146185.txt   459855

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pfe-20200518.xsd EX-101.SCH 4517
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20200518_def.xml EX-101.DEF 13697
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20200518_lab.xml EX-101.LAB 22678
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20200518_pre.xml EX-101.PRE 14665
11 EXTRACTED XBRL INSTANCE DOCUMENT d812767d8k_htm.xml XML 6239
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 20894069
SIC: 2834 Pharmaceutical Preparations